Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
Header
News Archive
News Archive Navigation
icon
News Archive Navigation Language
Language Preferences
Showing 382 results
August 2018
-
The ABCDEs of melanoma prevention and detection
Melanoma survivor T.J. Sharpe discusses skin cancer prevention and detection, and shares tips on how to keep you and your loved ones safe in the sun.
-
Teaming up with academia to discover medicines
The Novartis Faculty of Scholars initiative connects academic researchers with deep knowledge and big ideas to scientists in its drug discovery labs.
-
Neuroscientists target Alzheimer’s “silent stage”
Research exploring the first visible changes in the brain is helping scientists evaluate new potential treatments for Alzheimer’s.
-
New drug manufacturing tools change pharma chemistry
The modernization and miniaturization of pharmaceutical production could expand the range of ingredients medicinal chemists use to make new drugs.
-
Embracing big data to understand complex diseases
Researchers discover that networks of proteins circulating in the blood influence the development and progression of chronic diseases.
-
Discovery gives cystic fibrosis researchers new direction
Novartis-Harvard team identifies a new type of cell that is key to the disease.
July 2018
-
Meet Manuel Cobos, transplant surgeon and researcher
Follow Dr. Cobos as he works to provide a patient with a new liver and performs surgery using a tiny video camera.
-
Quest for a new measure of mental health
Novartis researchers are searching for more effective ways to discover drugs for neurological and psychiatric diseases.
-
Drug development gets big data analytics boost
With Nerve Live, Novartis is harnessing the power of data for the benefit of patients.
June 2018
-
Women in Science: Kristen Harrington-Smith
Kristen Harrington-Smith discusses her work as Vice President and Head of CAR-T US at Novartis Oncology.
-
Open resources at Novartis help drive innovation
With external help from Novartis, an Argentinian researcher was able to begin his search for a new medicine for tuberculosis.
Pagination
- ‹ Previous page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- …
- 32
- › Next page